Cardiovascular implantable electronic device endocarditis treated with daptomycin with or without transvenous removal

Heart and Lung: Journal of Acute and Critical Care

Volumn 41, Issue 6, 2012, Pages

  Tascini, Carlo ^a   Bongiorni, Maria Grazia ^a   Di Cori, Andrea ^a   Di Paolo, Antonello ^b   Polidori, Marina ^a   Tagliaferri, Enrico ^a   Fondelli, Serena ^a   Soldati, Ezio ^a   Ciullo, Ilaria ^a   Leonildi, Alessandro ^a   Danesi, Romano ^b   Coluccia, Giovanni ^a   Menichetti, Francesco ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Cardiovascular implantable electronic device; Daptomycin; Endocarditis; Transvenous removal

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; DAPTOMYCIN; GENTAMICIN; MEROPENEM; OXACILLIN; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATION; BLOOD CULTURE; CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICE ENDOCARDITIS; CLINICAL ARTICLE; DRUG TREATMENT FAILURE; ENDOCARDITIS; FEMALE; HUMAN; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS EPIDERMIDIS; METHICILLIN SENSITIVE STAPHYLOCOCCUS EPIDERMIDIS; METHICILLIN SENSITIVE STAPHYLOCOCCUS HOMINIS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL PARAMETERS; MINIMAL BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HOMINIS; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DAPTOMYCIN; DEVICE REMOVAL; ENDOCARDITIS, BACTERIAL; FOLLOW-UP STUDIES; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PACEMAKER, ARTIFICIAL; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

EID: 84868303957     PISSN: 01479563     EISSN: 15273288     Source Type: Journal    
DOI: 10.1016/j.hrtlng.2012.02.002     Document Type: Article

References (29)

1. Giannelli S., Nealon T.F. Four hundred consecutive patients with permanent transvenous pacemaker. J Thorac Cardiovasc Surg 1975, 69:1-7.
2. Bluhm G. Pacemaker infections: a clinical study with special reference to a prophylactic use of some isoxazolyl penicillins. Acta Med Scand 1985, 699(Suppl):1-62.
3. Aber N., Pras E., Copperman Y., Schapiro J.M., Meiner V., Lossos I.S., et al. Pacemaker endocarditis: report of 44 cases and review of the literature. Medicine (Baltimore) 1993, 73:299-305.
4. Cabell C.H., Heidenreich P.A., Chu V.H., Moore C.M., Stryjewski M.E., Corey G.R., et al. Increasing rate of cardiac device infections among Medicare beneficiaries: 1990-1999. Am Heart J 2004, 147:582-586.
5. Uslan D.Z., Sohail M.R., St. Sauver J.L., Friedman P.A., Hayes D.L., Stoner S.M., et al. Permanent pacemaker and implantable cardioverter-defibrillator infection: a population-based study. Arch Intern Med 2007, 167:669-675.
6. Kernodle D.S., Barg N.L., Kaiser A.B. Low-level colonization of hospitalized patients with methicillin-resistant coagulase-negative Staphylococci and emergence of the organisms during surgical antimicrobial prophylaxis. Antimicrob Agents Chemother 1988, 32:202-208.
7. Archer G.L., Climo M.W. Antimicrobial susceptibility of coagulase-negative Staphylococci. Antimicrob Agents Chemother 1994, 38:2231-2237.
8. Arbeit R.D., Maki D., Tally F.P., Campanaro E., Eisenstein B.I. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin Infect Dis 2004, 38:1673-1681. Daptomycin 98-01 and 99-01 Investigators.
9. Fowler V.G., Boucher H.W., Corey G.R., Abrutyn E., Karchmer A.W., Rupp M.E., et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006, 335:653-655.
10. Raad I., Hanna H., Jiang Y., Dvorak T., Reitzel R., Chaiban G., et al. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother 2007, 51:1656-1660.
11. Caron F., Kitzis M.D., Gutmann L., Cremieux A.C., Maziere B., Vallois J.M., et al. Daptomycin or teicoplanin in combination with gentamicin for treatment of experimental endocarditis due to a highly glycopeptide-resistant isolate of Enterococcus faecium. Antimicrob Agents Chemother 1992, 36:2611-2616.
12. Bongiorni M.G., Soldati E., Zucchelli G., Di Cori A., Segreti L., De Lucia R., et al. Transvenous removal of pacing and implantable cardiac defibrillating leads using single sheath mechanical dilatation and multiple venous approaches: high success rate and safety in more than 2000 leads. Eur Heart J 2008, 29:2886-2893.
13. Tascini C., Bongiorni M.G., Gemignani G., Soldati E., Leonildi A., Arena G., et al. Management of cardiac device infections: a retrospective survey of a non-surgical approach combining antibiotic therapy with transvenous removal. J Chemother 2006, 18:157-163.
14. Li J.S., Sexton D.J., Mick N., Nettles R., Fowler V.G., Ryan T., et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000, 30:633-638.
15. Polillo M., Tascini C., Lastella M., Malacarne P., Ciofi L., Viaggi B., et al. A rapid high-performance liquid chromatography method to measure linezolid and daptomycin concentrations in human plasma. Ther Drug Monit 2010, 32:200-205.
16. Sohail M.R., Uslan D.Z., Khan A.H., Friedman P.A., Hayes D.L., Wilson W.R., et al. Management and outcome of permanent and implantable cardioverter-defibrillator infections. J Am Coll Cardiol 2007, 49:1851-1859.
17. Love C.J., Wilkoff B.L., Byrd C.L., Belott P.H., Brinker J.A., Fearnot N.E., et al. Recommendations for extraction of chronically implanted transvenous pacing and defibrillator leads: indications, facilities, training. PACE 2000, 23:544-551.
18. Rundstrom H., kennegren C., Andersson R., Alestig K., Hogevik H. Pacemaker endocarditis during 18 years in Göteborg. Scand J Infect Dis 2004, 40:184-187.
19. Chua J.D., Wilkoff B.L., Lee I., Juratli N., Longworth D.L., Gordon S.M. Diagnosis and management of infections involving implantable electrophysiologic cardiac device. Ann Intern Med 2000, 155:604-608.
20. Del Rio A., Anguera I., Miro J.M., Mont L., Fowler V.G., Azqueta M., et al. Surgical treatment of pacemaker and defibrillator lead endocarditis: the impact of electrode lead extraction on outcome. Chest 2003, 124:1451-1459.
21. Mohan S.S., McDermott B., Cunha B. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin. Heart Lung 2005, 34:69-71.
22. Cunha B.A., Eisenstein L.E., Hamid N.S. Pacemaker-induced S. aureus mitral valve acute bacterial endocarditis complicated by persistent bacteremia from a coronary stent: cure with prolonged/high dose daptomycin without toxicity. Heart Lung 2006, 35:207-211.
23. Trappe H.J., Pfitzener P., Klein H., Wenzlaff P. Infections after cardioverter-defibrillator implantation: observations in 335 patients over 10 years. Br Heart J 1995, 73:20-24.
24. Nandyala R., Parsonnet V. One stage side-to-side replacement of infected pulse generators and leads. PACE 2006, 29:393-396.
25. Martone WJ, Katz DE. Community phenotype methicillin-resistant Staphylococcus aureus infections: an experience in the 2005 Cubicin Outcomes Registry and Experience (CORE 2005). In: Abstracts of the forty-fourth Infectious Diseases Society of America (IDSA) Meeting, Toronto, Ontario, Canada, 2006. Arlington, VA: IDSA; 2006:118.
26. Bongiorni M.G., Di Cori A., Soldati E., Zucchelli G., Arena G., Segreti L., et al. Intracardiac echocardiography in patients with pacing and defibrillating leads: a feasibility study. Echocardiography 2008, 25:632-638.
27. Rettig G., Doenecke P., Sen S., Volkmer I., Bette L. Complications with retained transvenous pacemaker electrodes. Am Heart J 1979, 98:587-594.
28. Kugener H., Rey J.L., Tribouilloy C., Hermida J.S., Jarry G., Avinée P., et al. Infectious endocarditis on permanent endocavitary pacemaker: value of echocardiography and review of the literature. An Cardiol Angeiol 1993, 42:331-338.
29. Eggiman P., Waldvogel F.A. Pacemaker and defibrillator infections. Infections associated with indwelling medical devices (3rd ed) 2000, ASM Press, Washington, DC, p. 247. F.A. Waldvogel, A.L. Bisno (Eds.).